Table 1.
Additions | Fold increase in GPDH activity |
---|---|
None | (1) |
GH (25 nM) alone | 86 ± 8 |
GH + cilostimide (10 μM) | 82 ± 7 |
GH + rolipram (10 μM) | 162 ± 6 |
GH + IBMX (500 μM) | 181 ± 22 |
GH + forskolin (10 nM) | 165 ± 18 |
Cilostimide alone | 1.5 ± 0.6 |
Rolipram alone | 13.7 ± 8 |
IBMX alone | 13 ± 5 |
Forskolin alone | 9.8 ± 5 |
GH + DOTAP | 84 ± 5 |
GH + “scrambled” PDE4A5 (10 μM) | 85 ± 7 |
GH + “antisense” PDE4A5 (10 μM) | 147 ± 10 |
Increased GPDH activity has been shown to serve as a marker for differentiation to adipocytes of the F442A cell line. GPDH activity in undifferentiated cells was 3.7 ± 0.2 nanokatals/mg of DNA. The data here show the change in cellular GPDH activity following treatment with 25 nM GH for 30 min. Data are means ± SD for n = 3 separate experiments. The changes in GPDH activity also reflected visual alterations in cell morphology (data not shown).